131 related articles for article (PubMed ID: 37277118)
1. Co-delivery of EGCG and melittin with self-assembled fluoro-nanoparticles for enhanced cancer therapy.
Sun M; Wu Y; Zhou Z; Liu S; Mao S; Li G
Aging (Albany NY); 2023 Jun; 15(11):4875-4888. PubMed ID: 37277118
[TBL] [Abstract][Full Text] [Related]
2. Engineered EGCG-Containing Biomimetic Nanoassemblies as Effective Delivery Platform for Enhanced Cancer Therapy.
Wu P; Zhang H; Yin Y; Sun M; Mao S; Chen H; Deng Y; Chen S; Li S; Sun B
Adv Sci (Weinh); 2022 May; 9(15):e2105894. PubMed ID: 35486032
[TBL] [Abstract][Full Text] [Related]
3. Synergetic regulation of cancer cells and exhausted T cells to fight cold tumors with a fluorinated EGCG-based nanocomplex.
Zhang J; Wang M; He D; Zhang L; Liu T; Wang K
J Nanobiotechnology; 2023 Nov; 21(1):420. PubMed ID: 37957632
[TBL] [Abstract][Full Text] [Related]
4. PD-L1 monoclonal antibody-conjugated nanoparticles enhance drug delivery level and chemotherapy efficacy in gastric cancer cells.
Xu S; Cui F; Huang D; Zhang D; Zhu A; Sun X; Cao Y; Ding S; Wang Y; Gao E; Zhang F
Int J Nanomedicine; 2019; 14():17-32. PubMed ID: 30587982
[TBL] [Abstract][Full Text] [Related]
5. Microfluidics-enabled fluorinated assembly of EGCG-ligands-siTOX nanoparticles for synergetic tumor cells and exhausted t cells regulation in cancer immunotherapy.
Han X; Zhang G; Wu X; Xu S; Liu J; Wang K; Liu T; Wu P
J Nanobiotechnology; 2024 Mar; 22(1):90. PubMed ID: 38439048
[TBL] [Abstract][Full Text] [Related]
6. Anti-PD-L1 peptide-conjugated prodrug nanoparticles for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death.
Moon Y; Shim MK; Choi J; Yang S; Kim J; Yun WS; Cho H; Park JY; Kim Y; Seong JK; Kim K
Theranostics; 2022; 12(5):1999-2014. PubMed ID: 35265195
[No Abstract] [Full Text] [Related]
7. Apatinib triggers autophagic and apoptotic cell death via VEGFR2/STAT3/PD-L1 and ROS/Nrf2/p62 signaling in lung cancer.
Xie C; Zhou X; Liang C; Li X; Ge M; Chen Y; Yin J; Zhu J; Zhong C
J Exp Clin Cancer Res; 2021 Aug; 40(1):266. PubMed ID: 34429133
[TBL] [Abstract][Full Text] [Related]
8. Enhanced Chemotherapeutic Efficacy of PLGA-Encapsulated Epigallocatechin Gallate (EGCG) Against Human Lung Cancer.
Zhang L; Chen W; Tu G; Chen X; Lu Y; Wu L; Zheng D
Int J Nanomedicine; 2020; 15():4417-4429. PubMed ID: 32606686
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin and siRNA-PD-L1 co-delivery with T7 modified ROS-sensitive nanoparticles for tumor chemoimmunotherapy.
Wan WJ; Qu CX; Zhou YJ; Zhang L; Chen MT; Liu Y; You BG; Li F; Wang DD; Zhang XN
Int J Pharm; 2019 Jul; 566():731-744. PubMed ID: 31212055
[TBL] [Abstract][Full Text] [Related]
10. Delivery of baicalein and paclitaxel using self-assembled nanoparticles: synergistic antitumor effect in vitro and in vivo.
Wang W; Xi M; Duan X; Wang Y; Kong F
Int J Nanomedicine; 2015; 10():3737-50. PubMed ID: 26045664
[TBL] [Abstract][Full Text] [Related]
11. Novel Nanotherapeutics for Cancer Immunotherapy by PD-L1-Aptamer-Functionalized and Fexofenadine-Loaded Albumin Nanoparticles.
Lai X; Yao F; An Y; Li X; Yang XD
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985529
[TBL] [Abstract][Full Text] [Related]
12. Immune checkpoint silencing using RNAi-incorporated nanoparticles enhances antitumor immunity and therapeutic efficacy compared with antibody-based approaches.
Won JE; Byeon Y; Wi TI; Lee CM; Lee JH; Kang TH; Lee JW; Lee Y; Park YM; Han HD
J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35228265
[TBL] [Abstract][Full Text] [Related]
13. Anti-Tumor and Anti-Metastasis Effects of Berbamine-Loaded Lipid Nanoparticles on Pancreatic Cancer.
Tang Z; Niu Y; Xu Z; Shi Y; Liu Y; Fu W; Zheng M; He H; Wu T
Anticancer Agents Med Chem; 2022; 22(18):3097-3106. PubMed ID: 35490430
[TBL] [Abstract][Full Text] [Related]
14. PLGA-encapsulated tea polyphenols enhance the chemotherapeutic efficacy of cisplatin against human cancer cells and mice bearing Ehrlich ascites carcinoma.
Singh M; Bhatnagar P; Mishra S; Kumar P; Shukla Y; Gupta KC
Int J Nanomedicine; 2015; 10():6789-809. PubMed ID: 26586942
[TBL] [Abstract][Full Text] [Related]
15. The activity against Ehrlich's ascites tumors of doxorubicin contained in self assembled, cell receptor targeted nanoparticle with simultaneous oral delivery of the green tea polyphenol epigallocatechin-3-gallate.
Ray L; Kumar P; Gupta KC
Biomaterials; 2013 Apr; 34(12):3064-76. PubMed ID: 23357370
[TBL] [Abstract][Full Text] [Related]
16. Folate decorated epigallocatechin-3-gallate (EGCG) loaded PLGA nanoparticles; in-vitro and in-vivo targeting efficacy against MDA-MB-231 tumor xenograft.
Kazi J; Sen R; Ganguly S; Jha T; Ganguly S; Chatterjee Debnath M
Int J Pharm; 2020 Jul; 585():119449. PubMed ID: 32464231
[TBL] [Abstract][Full Text] [Related]
17. Curcumin-human serum albumin nanoparticles decorated with PDL1 binding peptide for targeting PDL1-expressing breast cancer cells.
Hasanpoor Z; Mostafaie A; Nikokar I; Hassan ZM
Int J Biol Macromol; 2020 Sep; 159():137-153. PubMed ID: 32335119
[TBL] [Abstract][Full Text] [Related]
18. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
Pang L; Han S; Jiao Y; Jiang S; He X; Li P
Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
[TBL] [Abstract][Full Text] [Related]
19. Stable Loading and Delivery of Melittin with Lipid-Coated Polymeric Nanoparticles for Effective Tumor Therapy with Negligible Systemic Toxicity.
Ye R; Zheng Y; Chen Y; Wei X; Shi S; Chen Y; Zhu W; Wang A; Yang L; Xu Y; Peng J
ACS Appl Mater Interfaces; 2021 Dec; 13(47):55902-55912. PubMed ID: 34793125
[TBL] [Abstract][Full Text] [Related]
20. Green Tea Catechin Is an Alternative Immune Checkpoint Inhibitor that Inhibits PD-L1 Expression and Lung Tumor Growth.
Rawangkan A; Wongsirisin P; Namiki K; Iida K; Kobayashi Y; Shimizu Y; Fujiki H; Suganuma M
Molecules; 2018 Aug; 23(8):. PubMed ID: 30126206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
